Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients: Fig. 1.-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients: Fig. 1.

Published:2006-07-15 Issue:14 Volume:12 Page:4403s-4408s
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Sequist Lecia V.,Joshi Victoria A.,Jänne Pasi A.,Bell Daphne W.,Fidias Panos,Lindeman Neal I.,Louis David N.,Lee Jeffrey C.,Mark Eugene J.,Longtine Janina,Verlander Peter,Kucherlapati Raju,Meyerson Matthew,Haber Daniel A.,Johnson Bruce E.,Lynch Thomas J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?;Cancers;2022-04-30

2. Exceptional response to afatinib in a patient with persistent G719A EGFR-mutant NSCLC;Lung Cancer Management;2022-03

3. Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations;Journal of Thoracic Oncology;2021-05

4. The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers;memo - Magazine of European Medical Oncology;2020-01-24

5. Characterization of epidermal growth factor receptor ( EGFR ) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model;FEBS Open Bio;2019-09-07